Measles Virus Selectively Blind to Signaling Lymphocyte Activation Molecule as a Novel Oncolytic Virus for Breast Cancer Treatment

Gene Therapy - United Kingdom
doi 10.1038/gt.2012.44
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Predicting Receptor Functionality of Signaling Lymphocyte Activation Molecule for Measles Virus Hemagglutinin by Docking Simulation

Microbiology and Immunology
VirologyImmunologyMicrobiology
2017English

Function of Feline Signaling Lymphocyte Activation Molecule as a Receptor of Canine Distemper Virus

Journal of Veterinary Medical Science
Veterinary
2013English

Treatment of Breast Cancer Stem Cells With Oncolytic Herpes Simplex Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2012English

Measles Virus for Cancer Therapy

Current Topics in Microbiology and Immunology
AllergyImmunologyMicrobiology
English

Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted Against the Urokinase Receptor

Cancer Research
Cancer ResearchOncology
2009English

639. MicroRNA-Mediated Multi-Tissue-Detargeting of Oncolytic Measles Virus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

405. Measles Virus for Immunovirotherapy of Cancer

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Specific Elimination of CD133+ Tumor Cells With Targeted Oncolytic Measles Virus

Cancer Research
Cancer ResearchOncology
2013English

The Growth Profiles of Three Types of Canine Distemper Virus on Vero Cells Expressing Canine Signaling Lymphocyte Activation Molecule

Journal of Veterinary Medical Science
Veterinary
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy